Related Experiment Video
Updated: Jun 19, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
National Cancer Institute's Affordable Cancer Technologies (ACTs) Program
None:
The National Cancer Institute's Affordable Cancer Technologies (ACTs) Program marks a decade of success in supporting translational research. This initiative focuses on delivering affordable, scalable cancer prevention and control solutions for low- and middle-income countries. The program has funded 38 grants resulting in patents, publications, and the adoption of novel approaches, including point-of-care diagnostics for colorectal cancer and HPV, and new technologies for chemotherapy surveillance and cervical precancer treatment. ACTs accelerate life-saving innovations from the lab to real-world communities.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

